Like Sarkis et al. and Serth et al., we observed that high p53 expression was associated with tumor stage progression in NMIBC [17, 18], although both studies included a relatively small number of patients (n = 43 and n = 69, respectively). The gene discussed is TP53; the disease is neoplasm.